OTC · Drug Manufacturers - Specialty & Generic

Aion Therapeutic Inc. (ANTCF) Stock

$0.00 OTC: ANTCF Healthcare

Aion Therapeutic Inc. operates within Canada, focusing on the provision of medicinal cannabis products.

Valuation

MetricValue
Price$0.00
Market Cap$2.07M
P/E Ratio—
P/B Ratio—
P/S Ratio0.85
EPS (TTM)$-0.01
52-Week High$0.02
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE150.00%
ROA-26.86%
ROCE25.00%
Gross Margin32.29%
Operating Margin-43.12%
Net Margin0.00%
Debt/Equity-0.50
Current Ratio0.19

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-2.0M$-2.0M$-1.0M$-1.0M
Net Profit$-1.0M$-8.0M$-4.0M$0$-6.0M
EPS$-0.02$-0.09$-0.03$0.00$-0.02
Op Margin————-324.1%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$3.0M$2.0M$0$0$1.0M
Total Liabilities$1.0M$1.0M$3.0M$3.0M$5.0M
Cash$1.0M$0$0$0$0
Borrowings$1.0M$1.0M$1.0M$1.0M$2.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-1.0M$-2.0M$-1.0M$0$-1.0M
Investing Cash Flow$0$-3.0M$0$0$0
Financing Cash Flow$0$0$0$0$1.0M
Net Cash Flow$-1.0M$0$0$0$0
Free Cash Flow$-1.0M$-4.0M$-1.0M$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-2.54
FCF Yield-48.26%
Quick Ratio0.03
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Aion Therapeutic Inc.

Aion Therapeutic Inc. operates within Canada, focusing on the provision of medicinal cannabis products. The company, which commenced operations in 2011, adopted its current name, Aion Therapeutic Inc., in August 2020, having previously been known as Osoyoos Cannabis Inc. Its main administrative base is located in Toronto, Canada.

Aion Therapeutic Inc. (ANTCF) stock trades at $0.00 with a market capitalization of $2.07M. The stock is valued at price-to-sales of 0.85. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 100.0% below its 52-week high.

On profitability, Aion Therapeutic Inc. generates a return on equity (ROE) of 150.00% — well above the market average, a sign of a high-quality business, return on capital employed of 25.00%, an operating margin of -43.12%, a net profit margin of 0.00%.

Official website: bawangijo.com/2014/11

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides